Deans' stroke musings: Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, September 27, 2020

Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia

Well what the fuck are you going to do with this information to get survivors recovered? Prognosis is totally fucking useless to survivors.

Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia

Zheng X, Zhong C, Zhu Z, et al

Nutrition, Metabolism & Cardiovascular Diseases|September 17, 2020

This is the first study investigating the prognostic impact of matrix metalloproteinase-9 (MMP-9) among ischemic stroke patients stratified by dyslipidemia status. MMP-9 levels were assessed for 2,977 patients with acute ischemic stroke from 26 participating hospitals across China, and clinical outcome results were collected within one year of the ischemic stroke. According to results, increased MMP-9 has been correlated with poor prognosis only in patients with dyslipidemia within one-year after stroke, indicating that the prognostic importance of MMP-9 is modified by dyslipidemia status of patients with ischaemic stroke.